The Technical Analyst
Select Language :

Cyclerion Therapeutics [CYCN]

Exchange: NasdaqGS Sector: Healthcare Industry: Biotechnology

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

Cyclerion Therapeutics is listed at the NASDAQ Exchange

-7.55% $2.45

Last updated: 28 Nov 2021 @ 16:49 pm


FUNDAMENTALS
MarketCap: 106.12 mill
EPS: -1.633
P/E: 0.000
Earnings Date: Feb 23, 2022
SharesOutstanding: 43.32 mill
Avg Daily Volume: 0.425 mill
RATING 2021-11-26
B+
Neutral
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/203/204/201/212/213/21
Revenue
Gr.Profitn/an/an/an/a
Ebit
Asset
Debtn/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.000 | sector: PE 67.21
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE 0.000 | industry: PE 479.09
DISCOUNTED CASH FLOW VALUE
$4.15
(69.35%) $1.699
Date: 2021-11-28

Insider Trading

Date Person Action Amount type
2021-06-24 Fanucci Marsha Buy 10 000 Stock Option (Right to Buy)
2021-06-24 Lovell Stephanie Buy 10 000 Stock Option (Right to Buy)
2021-06-24 Mendelsohn Michael Buy 10 000 Stock Option (Right to Buy)
2021-06-24 Churchwell Kevin Buy 10 000 Stock Option (Right to Buy)
2021-06-24 Isacson Ole Buy 10 000 Stock Option (Right to Buy)
INSIDER POWER
79.07
Last 100 transactions
Buy: 11 647 325 | Sell: 15 650 431

Forecast: 14:40 - $2.46

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $2.44
Forecast 2: 14:00 - $2.43
Forecast 3: 14:40 - $2.46
SCORE
2.63
Buy
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.45 (-7.55% )
Volume 0.599 mill
Avg. Vol. 0.425 mill
% of Avg. Vol 141.05 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Cyclerion Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Cyclerion Therapeutics Inc

RSI

Intraday RSI14 chart for Cyclerion Therapeutics Inc
The Live Chart for Cyclerion Therapeutics Inc
Profile picture for
            Cyclerion Therapeutics Inc

CYCN

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases. Its product candidates include Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction; and IW-6463, an orally administered central nervous system (CNS)-penetrant sGC stimulator, which is in Phase I trials for neurodegenerative diseases. The company is also discovering liver-targeted sGC and lung-targeted sGC stimulators. Cyclerion Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals
Date Signal @
XRPUSDNov 28 - 11:440.914
BTCUSDNov 28 - 11:2954 102
DOGEUSDNov 28 - 11:29$0.198
XRPUSDNov 28 - 11:230.920
XRPUSDNov 28 - 11:100.924
XRPUSDNov 28 - 10:590.926
XRPUSDNov 28 - 10:550.928
BTCUSDNov 28 - 10:5354 420
DOGEUSDNov 28 - 10:46$0.201
XRPUSDNov 28 - 10:450.926

Stock Peers

Company Price Change
CYCN2.45-7.55%
ACST1.380-3.50%
CDTX1.470-2.65%
CLSN0.720-5.00%
COCP0.97018.57%
GRAY2.70-3.23%
LPTX2.549.48%
MBRX2.15-2.27%
NERV1.0600.00%
VERO1.370-2.14%
VYNT2.04-0.49%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.